High-Dose Ibuprofen for Patent Ductus Arteriosus in Extremely Preterm Infants: A Randomized Controlled Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High-Dose Ibuprofen for Patent Ductus Arteriosus in Extremely Preterm Infants: A Randomized Controlled Study

Published:2011-11-16 Issue:4 Volume:91 Page:590-596
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Dani C,Vangi V,Bertini G,Pratesi S,Lori I,Favelli F,Ciuti R,Bandinelli A,Martano C,Murru P,Messner H,Schena F,Mosca F

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference28 articles.

1. A Comparison of Ibuprofen and Indomethacin for Closure of Patent Ductus Arteriosus

2. Patent Ductus Arteriosus of the Preterm Infant

3. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin

4. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increasing the dose of ibuprofen with postnatal age to close a hemodynamically significant patent ductus arteriosus in very preterm infants;European Journal of Pediatrics;2023-05-19

2. Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews;Cochrane Database of Systematic Reviews;2023-04-11

3. Pharmacological Treatment of Patent Ductus Arteriosus in Preterm Infants;Congenital Heart Defects - Recent Advances;2022-09-21

4. Efficacy and safety of high versus standard dose ibuprofen for patent ductus arteriosus treatment in preterm infants: A systematic review and meta-analysis;Journal of Neonatal-Perinatal Medicine;2022-08-22

5. Eligibility Criteria and Representativeness of Randomized Clinical Trials That Include Infants Born Extremely Premature: A Systematic Review;The Journal of Pediatrics;2021-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3